首页> 外文期刊>Nursing of intrgrated traditional Chinese and Western medicine(Zhong-Xiyi Jiehe Huli ) >玻璃体腔注射雷珠单抗治疗早产儿视网膜病变的联合护理
【24h】

玻璃体腔注射雷珠单抗治疗早产儿视网膜病变的联合护理

机译:玻璃体腔注射雷珠单抗治疗早产儿视网膜病变的联合护理

获取原文
       

摘要

:Objective To summarize the nursing management of intravitreal injection of ranibizumab for the treatment of retinopathy of prematurity(ROP). Methods 〓Totally 35 cases of ROP(67 eyes)undergoing intravitreal injection of ranibizumab under the general anesthesia were included in this study. All pediatric patients received comprehensive nursing care during the treatment period and follow-up. Results 〓The intravitreal injection of ranibizumab was successfully performed in all pediatric patients. The ventilator support was successfully removed within 1 or 2 hours after the operation, and there was no ocular bleeding or infection occurred. After 1-year follow-up, all patients were recovered, in which 1 case undergoing laser photocoagulation for postoperative recurrence. Conclusion 〓It is required to carry out comprehensive nursing interventions during intravitreal injection of ranibizumab for the treatment of ROP.
机译::目的总结玻璃体内注射雷珠单抗的治疗方法,以治疗早产儿视网膜病变(ROP)。方法〓本研究共纳入35例ROP(67眼)全麻下玻璃体腔注射雷珠单抗。在治疗期间和随访期间,所有儿科患者均接受了全面的护理。结果〓所有患儿均成功进行了兰尼单抗的玻璃体内注射。术后1或2个小时内成功移除了呼吸机支撑,并且没有眼部出血或感染发生。一年的随访后,所有患者均康复,其中1例接受了激光光凝术以术后复发。结论〓玻璃体腔注射雷珠单抗治疗ROP时需要进行全面的护理干预。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号